BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:With two approved therapeutics and the field working to develo
 p the next generation of IPF drugs\, the opportunity to become the undisp
 uted\, most effective\, and disease-modifying agent on the market has nev
 er been greater.\n\nPacked with 4 days of insightful content\, the IPF Su
 mmit is back in Boston to help you delve into the persistent translationa
 l and clinical challenges in the space.\n\nThis industry’s undisputed for
 um will unite 150+ industry giants and pioneering academics in-person inc
 luding Boehringer Ingelheim\, Genentech\, Novartis\, AbbVie\, Gilead\, Fe
 rnando Martinez\, Naftali Kaminski\, Toby Maher\, and many more. Join the
 m to gain end-to-end insights to empower you with the knowledge you need 
 for your 2022/2023 IPF research and drug development goals.\n\nOrganizati
 ons across autoimmunity\, regenerative medicine\, and inflammation are tu
 rning towards IPF as a strategic opportunity. Attend this dynamic meeting
  filled with formal presentations\, interactive workshops\, panel discuss
 ions\, and organized networking to fast track your understanding\, strate
 gize success\, and advance the IPF drug development frontier.\n
DTEND:20220901T170000
DTSTAMP:20260512T234009Z
DTSTART:20220829T082500
LOCATION:The Westin Boston Seaport District\, 425 Summer Street\, Boston\,
  Massachusetts\, 02210\,
SEQUENCE:0
SUMMARY:With two approved therapeutics and the field working to develop th
 e next generation of IPF drugs\, the opportunity to become the undisputed
 \, most ef...
UID:4a107f7a-8371-46cd-b1ee-b96d98a8cd33
END:VEVENT
END:VCALENDAR